Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

L. Erdem, E. Giovannetti, L.G. Leon, R. Honeywell, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1649-1659
JournalCurrent Topics in Medicinal Chemistry
Volume12
Issue number15
DOIs
Publication statusPublished - 2012

Cite this

@article{29cf4b208e1f486086ed8181ae631a07,
title = "Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib",
author = "L. Erdem and E. Giovannetti and L.G. Leon and R. Honeywell and G.J. Peters",
year = "2012",
doi = "10.2174/156802612803531333",
language = "Undefined/Unknown",
volume = "12",
pages = "1649--1659",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "15",

}

Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib. / Erdem, L.; Giovannetti, E.; Leon, L.G.; Honeywell, R.; Peters, G.J.

In: Current Topics in Medicinal Chemistry, Vol. 12, No. 15, 2012, p. 1649-1659.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

AU - Erdem, L.

AU - Giovannetti, E.

AU - Leon, L.G.

AU - Honeywell, R.

AU - Peters, G.J.

PY - 2012

Y1 - 2012

U2 - 10.2174/156802612803531333

DO - 10.2174/156802612803531333

M3 - Article

VL - 12

SP - 1649

EP - 1659

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 15

ER -